We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Register Free
Advertise with Us
Latest Issue
Latest Issue

Download Mobile App




In Other News

Image: Pathlight combines WGS and dPCR to identify and longitudinally track large‑scale genomic changes, known as structural variants (photo courtesy of SAGA Diagnositcs)

Roche Affiliate Expands MRD Portfolio with SAGA Acquisition

Foundation Medicine, Inc., an independent affiliate of Roche, announced plans to expand its monitoring portfolio with SAGA Diagnostics’ Pathlight, a personalized, tumor-informed molecular residual disease (MRD) platform. Read more
20 Apr 2026 | Industry
Image: Professor Rajesh Ramanathan, from the Sir Ian Potter NanoBioSensing Facility and NanoBiotechnology Research Laboratory in RMIT’s School of Science, and Dr Pabudi Weerathunge examine colour changes during a laboratory test used to identify golden staph strains (photo courtesy of Will Wright, RMIT University)

Rapid Color Test Stratifies Virulent and Resistant Staph Strains

Staphylococcus aureus (golden staph) remains a leading cause of infection-related mortality worldwide, responsible for more than a million deaths each year. Read more
18 Apr 2026 | Microbiology
Image: A new cfDNA epigenetic assay correlates with osteosarcoma status, supporting blood-based monitoring when ctDNA is scarce (photo courtesy of 123RF)

Blood-Based Epigenetic Signals Enable Osteosarcoma Disease Monitoring

Osteosarcoma is a rare but aggressive pediatric bone cancer where recurrence and metastasis remain difficult to detect early. Read more
17 Apr 2026 | Molecular Diagnostics
Image: Susceptible HLA backgrounds and high-risk EBV variants are linked to increased cancer risk (photo credit: Adobe Stock)

Host–Virus Genetic Interactions Drive Nasopharyngeal Cancer Risk

Epstein–Barr virus (EBV) infects more than 95% of adults worldwide, yet only a small fraction develops EBV‑associated cancers such as nasopharyngeal carcinoma. Read more
17 Apr 2026 | Molecular Diagnostics
Image: The GenoPredict assay from Predicta Biosciences is available to Tempus Life Sciences partners to support exploratory research and clinical development programs (photo courtesy of Shutterstock)

Partnership Expands Ultrasensitive WGS Assay for for Hematologic Malignancies and MRD Monitoring

Tempus AI and Predicta Biosciences announced the commercial expansion of a co-branded whole‑genome sequencing assay GenoPredicta, which is intended for comprehensive genomic characterization of hematologic malignancies and measurable residual disease monitoring. Read more
17 Apr 2026 | Industry
Image: NTU Assoc Prof Y.C. Chen (right) holding the new biochip, which can detect miRNA in 20 minutes using AI, with his PhD student Fu Bowen behind him (left) (photo courtesy of Nanyang Technological University)

AI-Enabled Biochip Detects microRNA Biomarkers in Minutes

Detecting circulating microRNAs, small RNA molecules linked to diverse diseases, is technically challenging because they are scarce and often share similar sequences. Read more
17 Apr 2026 | Molecular Diagnostics
Image: (From left to right) Nizar Bahlis, MD, Holly Lee, MD, Paola Neri, MD, Ph.D. (photo courtesy of Riley Brandt, University of Calgary)

Study Identifies Protein Changes Driving Immunotherapy Resistance in Multiple Myeloma

Multiple myeloma is the second most common adult blood cancer and frequently relapses despite immunotherapies that can extend survival. Read more
17 Apr 2026 | BioResearch
Image: The assay evaluates multiple cancer‑associated signals together to support risk assessment for early detection (photo credit: Adobe Stock)

Blood Test Detects Early Pancreatic Cancer in High-Risk Patients

Earlier identification of pancreatic cancer in individuals at elevated risk remains an urgent unmet need in oncology, with strong interest in noninvasive strategies. Read more
17 Apr 2026 | Molecular Diagnostics
Image: QIAGEN is showcasing QIAsymphony Connect at AACR 2026 among other solutions addressing key oncology research needs (phot courtesy of Qiagen)

QIAGEN Showcases Integrated Sample-to-Insight Oncology Solutions at AACR 2026

At the American Association for Cancer Research (AACR) Annual Meeting 2026, QIAGEN is presenting an expanded portfolio of Sample-to-Insight solutions designed to streamline oncology workflows from sample preparation through multi-omics analysis and data interpretation. Read more
17 Apr 2026 | Industry
Image: The STRIPE platform enables deep sequencing of full-length RNA molecules for any customized disease-relevant panel (photo courtesy of Shutterstock)

Long-Read RNA Sequencing Platform Improves Rare Disease Diagnosis

Rare genetic diseases often evade definitive diagnosis even after exome or genome sequencing, leaving many families without clear answers. Read more
17 Apr 2026 | Molecular Diagnostics
Image: Overview diagram of estimated cumulative risk up to age 85 for carriers of pathogenic variants in the BRCA1/2 genes (photo courtesy of RIKEN)

Genetic Analysis Identifies BRCA-Linked Risks Across Multiple Cancers

Pathogenic variants in BRCA1 and BRCA2 are well established drivers of hereditary breast and ovarian cancer, and have also been linked to pancreatic and prostate cancers. Read more
17 Apr 2026 | BioResearch
Image: The ultrasensitive test detected M. tuberculosis DNA in patients unlikely to be diagnosed with current methods (photo courtesy of Adobe Stock)

Ultrasensitive Assay Reveals Previously Undetected Tuberculosis in Hospital Patients

Tuberculosis remains the leading cause of death from an infectious disease worldwide, and diagnosis can be difficult when bacterial load is low or disease is atypical. Read more
16 Apr 2026 | Molecular Diagnostics
Image: New findings provide strong evidence that Barrett’s esophagus initiates esophageal adenocarcinoma and identify markers for earlier detection (photo courtesy of Shutterstock)

Study Confirms Barrett’s Esophagus as Precursor to Esophageal Cancer

Esophageal adenocarcinoma is rising in Western countries and is often detected late, limiting treatment options. Read more
16 Apr 2026 | Molecular Diagnostics
Image: Flow chart summarizing workflow pipeline (Thomas, V., Nyamundanda, G., Lärkeryd, A. et al. Sci Rep 16, 8843 (2026). https://doi.org/10.1038/s41598-026-39189-w)

AI Tool Predicts Non-Response to Targeted Therapy in Colorectal Cancer

Advanced bowel cancer remains difficult to treat, and many patients receive targeted therapies that do not help them but still cause harm. Read more
16 Apr 2026 | Technology

Channels

Clinical Chemistry

view channel
Study Finds ApoB Testing More Effective Than LDL for Guiding Lipid Therapy
AI-Enabled POC Test Quantifies Multiple Cardiac Biomarkers
Next Generation Automated Analyzers Increase Throughput for Clinical Chemistry and...
Image: Plasma pTau217 testing can predict future amyloid accumulation and cognitive decline in cognitively healthy older adults (photo courtesy of Shutterstock)

Blood Test Predicts Alzheimer Disease Risk Before Imaging Changes and Symptoms

Alzheimer's disease often advances silently for years, making timely risk stratification difficult in routine practice. Current approaches to detect pathology can involve lumbar puncture or positron emission... Read more

Molecular Diagnostics

view channel
CE-Marked Blood Test Enables Monitoring of Neuroinflammation in Multiple Scleros...
Ultrasensitive Assay Tracks Resistance Mutations MRD Monitoring
Extracellular Vesicle RNA Biomarkers Enable Noninvasive IBD Diagnosis and Monito...
Image: Dengue is among the most widespread mosquito-borne infections, yet early risk stratification can be difficult when symptoms overlap with other febrile illnesses (photo courtesy of Adobe Stock)

Urine-Based Assay Predicts Severe Dengue Risk Early

Dengue is among the most widespread mosquito-borne infections, yet early risk stratification can be difficult when symptoms overlap with other febrile illnesses. Only about 2% to 5% of patients develop... Read more

Hematology

view channel
Prognostic Tool Guides Personalized Treatment in Rare Blood Cancer
New Platelet Function Assay Enables Monitoring of Antiplatelet Therapy
Open Multi-Omics Platform Identifies Prognostic Subtypes in Blood Cancers
Image: The findings suggest anemia may signal underlying disease, with routine blood tests helping identify patients needing closer follow-up (photo courtesy of 123RF)

Routine Blood Test Parameters Link Anemia to Cancer Risk and Mortality

Anemia detected in routine care can signal underlying pathology and is frequently encountered in adults. Because it is defined by hemoglobin levels below the normal range, it is often evaluated with red... Read more

Immunology

view channel
Combined Screening Approach Identifies Early Leprosy Cases
Antibody Blood Test Identifies Active TB and Distinguishes Latent Infection
FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Car...
Image: The results indicate that routine clinical surveillance underestimates influenza’s contribution to winter deaths (photo courtesy of Adobe Stocks)

Study Finds Influenza Often Undiagnosed in Winter Deaths

Seasonal influenza drives substantial excess mortality, yet its contribution is often obscured when infections go undiagnosed near the time of death. Many deaths occur outside hospitals or in older adults... Read more

Microbiology

view channel
RNA-Based Workflow Identifies Active Skin Microbes for Dermatology Research
Cost-Effective Sampling and Sequencing Workflow Identifies ICU Infection Hotspot...
New Bacterial Target Identified for Early Detection of Noma
Image: The CE-IVDR-certified QIAstat-Dx BCID GPF Plus AMR Panel identifies 20 gram-positive bacterial and fungal targets and 10 antimicrobial resistance markers directly from positive blood cultures and colonies in about one hour (photo courtesy of Adobe Stock)

Syndromic Panel Enables Rapid Identification of Bloodstream Infections

Bloodstream infections require rapid identification of causative pathogens and resistance determinants to guide therapy, yet laboratories often face pressure to deliver clinically relevant results quickly... Read more

Pathology

view channel
Collaboration Applies AI Pathology to Predict Response to Antibody-Drug Conjugat...
AI Improves Completeness of Complex Cancer Pathology Reports
AI Tool Predicts Chemotherapy Response in Small Cell Lung Cancer
Image: Eduard Batlle and Elena Sancho, ICB researchers and study authors (photo courtesy of Institute for Research in Biomedicine)

Biomarker Predicts Immunotherapy Response and Prognosis in Colorectal Cancer

Colorectal cancer is common and often lethal, and therapeutic decision-making is complicated by heterogeneous tumor microenvironments. Immunotherapy benefits only a small subset of patients, around 5%,... Read more

Technology

view channel
Noninvasive Sputum Test Detects Early Lung Cancer
New AI Tool Enables Rapid Treatment Selection in Pediatric Leukemia
Breakthrough Mass Spectrometry Design Could Enable Ultra-Low Abundance Detection
Image: The PrepQuant System is assay-agnostic and generates highly concentrated genomic DNA and cfDNA suitable for NGS, qPCR and dPCRassays (photo courtesy of 123RF)

Integrated System Streamlines Pre-Analytical Workflow for Molecular Testing

Pre-analytical variation remains a leading source of inconsistent molecular test results and added costs, particularly when laboratories rely on multiple instruments and protocols. Standardizing nucleic... Read more

Industry

view channel
Junction, GRAIL Enable Scalable Access to Multi-Cancer Detection Test
GRAIL Partners with Epic to Integrate Multi-Cancer Test into EHR
Global Partnership Aims to Streamline NGS Tumor Profiling in Oncology Trials
Image: The Access MeMed BV assay is validated for use across Beckman Coulter’s installed base of DxI 9000 and Access 2 immunoassay analyzers (photo courtesy of Beckman Coulter)

Beckman Coulter Gains CE Mark for Rapid Assay Distinguishing Bacterial vs Viral Infections

Clinicians often struggle to distinguish bacterial from viral infections at first presentation because symptoms overlap and definitive culture or molecular results can take hours or days.... Read more

LabMedica

About Us
Advertising Info
Subscription
Client Login
Privacy Policy
Terms of Service
Cookie Policy
Journal Info
Contact Us

Channels

Clinical Chem.
Molecular Diagnostics
Hematology
Immunology
Microbiology
Pathology
Technology
BioResearch
Industry
Events
Focus
Webinars

Features

Events Product Showcase LinkXpress Whitepapers archive Video Library

Partner Sites

LabMedica ExpoHospiMedica.com Globetech.net

Archive:

BioResearch
COVID-19

2026
WHX Labs Dubai 2025
Medica ADLM MEDLAB 2024
Medica ADLM

 

Medlab 2023
Medica AACC EUROMEDLAB Medlab 2022
MEDICA AACC ECCMID
Copyright © 2000-2026 Globetech Media. All rights reserved.
MOBILE | FULL SITE